CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Rodrigo Ortiz

  • Events
  • Clinicians
  • Researchers
  • ATMPs
  • Regulation
  • Research
  • Rodrigo Ortiz
15 April 2025

ADVANCE 5-day Summer School on Cell and Gene Therapies

The next ADVANCE school on ATMP from Faculty of Pharmacy will happen here in Ljubljana. We think is a great FREE opportunity to learn more about ATMPs. Learn more in the official page of ...

Summer school
  • Events
  • Pacients
  • Business Model
  • Investment
  • CTGCT
  • NIC
  • Rodrigo Ortiz
13 March 2025 Event Date: 12 March 2025 do: 12 March 2025 •

Prime Minister of Slovenia Dr. Robert Golob visits the Kemijski Inštitut to discuss the CTGCT plans

Yesterday, Dr. Robert Golob, Prime Minister of the Slovenian Government, visited the Kemijski inštitut - National Institute of Chemistry.

Pxl 20250313 084506170.mp
  • Events
  • Clinicians
  • Researchers
  • Gen Therapy
  • Research
  • CTGCT
  • Rodrigo Ortiz
12 March 2025 Event Date: 17 March 2025 • 14:00 do: 17 March 2025 • 15:00

Gene Therapy: Triumphs, Challenges, and Future Directions

Lecture by Luis Pereira de Almeida on the 17th of March at the Kemijski Inštitut

Luis Pereira Lecture March 2025
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Articles
  • Pacients
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 February 2025

How Patient Advocacy is Driving Breakthroughs to Treat CTNNB1 Syndrome

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Paving The Way Ctnnb1
  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
25 February 2025

Controlling Cells With Chemically Switchable Antibodies: A New Opportunity For Precision Therapy

Imagine being able to turn a cell’s behavior ON or OFF, just like flipping a light switch. That’s exactly what scientists have achieved with the innovative technology presented in this paper published in the ...

Graphical Abstract Controlling Cells
  • Articles
  • Pacients
  • Researchers
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
28 January 2025

The research on combining cytokines with pyroptosis is gaining widespread media coverage

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

Odmevi Sara N Iva
  • Media Releases
  • Pacients
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
10 January 2025

Head of CTGCT research selected as breakthrough discovery by the national TV in Slovenia

Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ...

Mojca Rtve1 Discover Of The Year 2024
  • Articles
  • Clinicians
  • Pacients
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
7 January 2025

Combining cytokines and pyroptosis, a promising weapon against cancer

A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ...

Cytokine Pyroptosis
  • Latest
  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • Research
  • CTGCT
  • Rodrigo Ortiz
  • Rodrigo Ortiz
11 December 2024

CTGCT Newsletter, 1st year in review

Welcome to the first CTGCT Newsletter featuring a selection of the articles we're most proud of in the last year.

  • Articles
  • Media Releases
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
6 December 2024

CTGCT’s Innovation Report on Gene and Cell Therapy

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

Innovation Report Abstract
  • Articles
  • Pacients
  • Gen Therapy
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
22 November 2024

MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death

A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways.

Myd88 Blogpost Cover

Posts pagination

1 2 3

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna